Protein Science Corporation announces release of flu vaccine

Protein Sciences Corporation announced on Thursday that it expects the first batch of its Flublok influenza vaccine for the 2013/2014 flu season to be ready for release before Thanksgiving.

The Centers for Disease Control and Prevention recommes vaccination against the influenza at least two weeks prior to the onset of the flu season, since the body takes at least two weeks to develop antibodies to fight against the influenza virus. The early release of the Flublok influenza vaccine allots enough time to follow the CDC's recommendation.

Flublok was approved by the U.S. Food and Drug Administration on January 16. The vaccine was made by only using the active ingredient which protects against the influenza, not by growing the influenza virus.

Flublok is 100 percent egg-free, contains three times as much active flu vaccine than traditional flu vaccines, uses modern cell culture technology and is safe for people with egg, antibiotic and latex allergies.

The CDC recommends Flublok for adults between the ages of 18 and 49. Flublok is also the CDC's choice for persons between 18 and 49 years of age with a known or suspected egg allergy.

FFF Enterprises has exclusive rights to the distribution of Flublok. The organization recommends vaccinators place orders as soon as possible to ensure delivery.